Evidence map›Paper›PMID 32355476›Full record

ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2020

Molecular Basis of ABO Variants Including Identification of 16 Novel

Yan-Ling Ying, Xiao-Zhen Hong, Xian-Guo Xu, Shu Chen, Ji He, Fa-Ming Zhu, Xin-You Xie

Abstract read
In one paragraph

Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. A Rare VariantTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analysis of the Genomic Sequence ofFrontiers in immunology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan-Ling YingSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiao-Zhen HongBlood Center of Zhejiang Province, Hangzhou, China.
Xian-Guo XuBlood Center of Zhejiang Province, Hangzhou, China.
Shu ChenBlood Center of Zhejiang Province, Hangzhou, China.
Ji HeBlood Center of Zhejiang Province, Hangzhou, China.
Fa-Ming ZhuBlood Center of Zhejiang Province, Hangzhou, China.
Xin-You XieSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe characteristic of ABO blood subgroup is crucial for elucidating the mechanisms of such variant phenotypes and offering useful information in blood transfusion.

methodsIn total, 211 ABO variants including part of available family members were investigated in this study. The phenotypes of these individuals were typed with serologic methods. The full coding regions of

resultsForty-eight distinctly rare

conclusionsThe molecular basis of ABO variants was analyzed, and 16 novel

Indexed as

ABO variantsMolecular basisNovel ABO alleleSequence-based typing

Identifiers

PMID32355476
PMCPMC7184853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.